The German Association for Chronic Inflammatory Bowel Diseases (DACED) is a working group of the German Society for Digestive and Metabolic Diseases (DGVS)
DACED serves the scientific exchange within basic science and clinical research in the field of IBD. The aim is to find causes of IBD and to improve the treatment of patients through coordinated and targeted research.
There is a close collaboration with the Competence Network on Intestinal Diseases (Kompetenznetz Darmerkrankungen) as well as with the German IBD Study Group. Since 2011, the German representatives of the European Crohn’s- and Colitis Organization (ECCO) have been elected together with the Competence Network Intestinal Diseases.
Since 2014, DACED has been integrated into the Competence Network for Intestinal Diseases. Accordingly, it provides two members in the board of the competence network. With the integration of the DACED, the non-clinical IBD research landscape is included in the competence network and thus the topic „IBD“ is represented in Germany across all areas by the competence network. The aim of the cooperation agreement is to support experimental and clinical work in the field of inflammatory bowel diseases across the network boundaries to strengthen research and to improve the care of IBD sufferers.
Die DACED dient dem wissenschaftlichen Austausch in der grundlagenwissenschaftlichen und klinischen Forschung auf dem Gebiet der CED. Ziel ist es, durch koordinierte und gezielte Forschung die Ursachen von CED zu erforschen und die Behandlung der Patient:innen zu verbessern. Es besteht eine enge Zusammenarbeit mit dem Kompetenznetz Darmerkrankungen sowie mit der Deutschen IBD-Studiengruppe. Seit 2011 werden gemeinsam mit dem Kompetenznetz Darmerkrankungen die deutschen Vertreter:innen in der European Crohn's- and Colitis Organization (ECCO) gewählt. Seit 2014 ist die DACED in das Kompetenznetz Darmerkrankungen integriert. Entsprechend stellt es ein bis zwei Mitglieder im Vorstand des Kompetenznetzes. Mit der Integration des DACED wird die nichtklinische IBD-Forschungslandschaft in das Kompetenznetz einbezogen und somit das Thema "IBD" in Deutschland über alle Bereiche hinweg durch das Kompetenznetz vertreten. Ziel der Kooperationsvereinbarung ist es, experimentelle und klinische Arbeiten auf dem Gebiet der chronisch entzündlichen Darmerkrankungen über die Netzwerkgrenzen hinaus zu unterstützen, um die Forschung zu stärken und die Versorgung von IBD-Betroffenen zu verbessern.

Board Member's 2024

PD Dr. med. Irina Blumenstein
Prof. Dr. med. Claudia Günther
Former Board Members
Dr. med. Florian Tran
Prof. Dr. med. Raja Atreya​, Prof. Dr. med. Michael Scharl
PD Dr. med. Michael Schumann
PD Dr. med. Michael Schumann
Prof. Dr. med. Dominik Bettenworth, Prof. Dr. med. Samuel Huber
Dr. med. Konrad Aden
Prof. Dr. med. Sebastian Zeißig
Prof. Dr. med. Anne Krug, Dr. med. Wolfgang Reindl
PD Dr. med. Jonas Mudter, PD Dr. med. Clemens Neufert
Dr. med. Jürgen Büning, Dr. med. Christian Sina
PD Dr. med. Oliver Bachmann
Prof. Dr. med. Christian Maaser
PD Dr. med. Jan Wehkamp
PD Dr. med. Tanja Kühbacher, PD Dr. med. Susann Nikolaus


Award Winner 2023 - Dr. Jay Patankar

Kiel, July 2023 - The German Association for Inflammatory Bowel Diseases (DACED), a working group of the DGVS (German Society for Gastroenterology, Digestive and Metabolic Diseases), awarded the DACED Future Prize for the 14th time at its 35th annual conference. The prize, worth 7,500 Euro, is donated by Ferring Arzneimittel GmbH, Kiel, and is awarded annually for scientifically excellent experimental or clinical-scientific work in the field of inflammatory bowel diseases. The chairman of the DACED 2023 Florian Tran, MD, presented the award to PD Dr. rer. nat. Jay Patankar of Erlangen University Hospital for his work on functional modulation of the epithelial barrier by paracrine oxylipins. Dr. Patankar has been able to show that pharmacological activation of the PGE2 (prostaglandin)/EP4 receptor axis with regard to the epithelial barrier is protective in murine colitis models as well as in epithelial organoids from IBD patients. In addition, he found that cultured colonic fibroblasts are the primary source of PGE2, which is regulated by IL1 family cytokines. Dr. Patankar's research highlights the important role of the epithelial barrier in maintaining intestinal health and disease preventing. By further elucidating the underlying mechanisms, future therapies can be specifically identified.

Press Releases

From left: Dr. med. Florian Tran, PD Dr. rer. nat. Jay Patankar, Dr. med. Christoph Goemann
Photo: Kompetenznetz Darmerkrankungen e. V.

Next Event

June 7-8, 2024

36th DACED
Annual Conference


Sign up

Supported by a donation from

Nach oben scrollen